NEW YORK (GenomeWeb News) - Codon Devices successfully built a sequence-verified 35-kilobase genetic construct for Microbia's Precision Engineering Unit, the company said today.
The construct is an 80-percent synthetic gene cluster containing a biosynthetic pathway to optimize production of an active pharmaceutical ingredient.
Financial terms were not disclosed.
Already have a GenomeWeb or 360Dx account?Login Now.
CNN reports that researchers have tied a new variant to opioid addiction risk.
Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.
An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.
In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.